# Regenerative Biologics Inc. – FDA Inspection, May 1, 2013

Source: https://www.keypedia.com/records/fda_inspections/regenerative-biologics-inc/f65fcbac-8b9d-4aa2-8ff6-b0ef3c191328
Source feed: FDA_Inspections

> FDA inspection 829271 of Regenerative Biologics Inc., May 01, 2013. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 1271. 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 829271
- Company Name: Regenerative Biologics Inc.
- Inspection Date: 2013-05-01
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1293608 - 2025-11-18
- FDA Inspection 1202949 - 2023-04-13
- [FDA Inspection 1117126 - 2020-02-06](https://www.keypedia.com/records/fda_inspections/regenerative-biologics-inc/284ab3f1-a5df-46e0-8fdb-8c33ebe08e6d)
- FDA Inspection 1026631 - 2017-08-15
- FDA Inspection 922553 - 2015-04-16

Company: https://www.keypedia.com/companies/regenerative-biologics-inc/546031f7-fb56-45e9-bc3c-5c19ff0e39b4

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d